EGFR and cancer: Furthermore, mutated p53 may confer various gain-of-function activities that affect cancer-related gene expression and possibly make the tumor more dependent on EGFR signaling [7,37], which, in turn, could make the tumor more sensitive to EGFR-TKIs.